These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 35558075)

  • 1. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
    Cai Y; Liu J; Wang B; Sun M; Yang H
    Front Immunol; 2022; 13():856376. PubMed ID: 35558075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc utilization by microglia in Alzheimer's disease.
    Shippy DC; Oliai SF; Ulland TK
    J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
    Uddin MS; Lim LW
    Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets.
    AmeliMojarad M; AmeliMojarad M
    CNS Neurosci Ther; 2024 Jul; 30(7):e14856. PubMed ID: 39031970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
    Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H
    J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.
    Wang Z; Weaver DF
    Int Immunopharmacol; 2022 Sep; 110():109070. PubMed ID: 35978514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies.
    Sun Z; Zhang X; So KF; Jiang W; Chiu K
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia in Alzheimer's Disease.
    Süß P; Schlachetzki JCM
    Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.
    Anwar S; Rivest S
    Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117
    [No Abstract]   [Full Text] [Related]  

  • 11. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia in Alzheimer's Disease in the Context of Tau Pathology.
    Perea JR; Bolós M; Avila J
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
    Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
    Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials.
    Boche D; Nicoll JAR
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):623-640. PubMed ID: 32643143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
    Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.